ReMiNCT07931482
Revitalis - Midface (Cheek Area)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Skin Smoothness: Responder status assessed by independent evaluator at site
Timeframe: week 12
Secondary (16)
Skin Smoothness: Responder status assessed by independent evaluator at site - other timepoints
Skin Smoothness: Responder status assessed by blinded panel
Skin Smoothness: Change from Baseline assessed by independent evaluator at site
Skin Smoothness: Change from baseline assessed by blinded panel
Cheek Lines: Responder Status assessed by independent evaluator at site
Show 11 moreShow less
Cheek Lines: Change from Baseline assessed by independent evaluator at site
Cheek Lines: Responder status assessed by blinded panel
Cheek Lines: Change from Baseline assessed by blinded panel
FACE-Q™ Satisfaction with Skin
FACE-Q™ Satisfaction with Outcome
FACE-Q™Lines Appraisal
GAIS assessed by the participants
GAIS assessed by an independent evaluator at site
Skin hydration: change from baseline
Skin elasticity: change from baseline
Skin firmness(tone): change from baseline
Arms and interventions
croma revitalisExperimental
Croma revitalis is a (CE)-marked, non-active, single-use hyaluronic acid-based medical device, intended for intradermal administration in the midface (cheek area).
Devices: Croma revitalis
Sites
1 site in 1 country
- YuvellVienna, Austria